Avid Bioservices opens new Early Phase Center of Excellence
OrthoTrophix completes patient enrolment in TPX-100 Phase 2b clinical trial
Bloom Science doses first patient in Phase 1b trial of BL-001 for obesity treatment
Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA
Epredia signs EU distribution deal with Mindpeak for AI pathology software
AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia
Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA
Astellas Pharma signs global strategic collaboration with Vir Biotechnology
Illumina sets out 18-Month NovaSeq X roadmap to boost sequencing performance and scale
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial
NICE recommends epcoritamab for relapsed or refractory follicular lymphoma
AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL
FDA approves Genentech oral Venclexta plus AstraZeneca's Calquence combination for first-line CLL